European Ulcerative Colitis Patients Have Low Medication Adherence, Tillotts Pharma Survey Shows

European Ulcerative Colitis Patients Have Low Medication Adherence, Tillotts Pharma Survey Shows
More than 90% of the patients who suffer from ulcerative colitis in Europe have either low or medium adherence to their medication, which increases patients’ probability of suffering relapses up to five times. These conclusions are from a survey recently conducted and reported by the company Tillotts Pharma and presented at the 10th Congress of the

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *